News

All news

2020-04-28

ACCORD HEALTHCARE LAUNCH DUTASTERIDE/TAMSULOSIN HYDROCHLORIDE

Accord Healthcare is delighted to announce the launch of Dutasteride/Tamsulosin Hydrochloride, 0.5 mg/0.4 mg, which will be available in a pack size of 30 hard capsules.

This medicine is indicated for: the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH), and the reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC will be available on the www.hpra.ie website and here for Healthcare Professionals. 

Date of Preparation: February 2020. IE-01474

 

 

All news